Healthcare Services

Constipation Treatment Market Revenue Growth Expected to Reach $18.71 Billion by 2030 with 8% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Constipation Treatment Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The constipation treatment market size has experienced strong growth in recent years. It is projected to increase from $12.71 billion in 2025 to $13.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This growth in the historic period can be linked to the high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, reliance on traditional laxatives, and aging population growth.

The constipation treatment market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $18.72 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.0%. This projected growth during the forecast period is fueled by several factors, including an increase in chronic constipation diagnoses, greater opioid consumption, heightened public understanding of gut health, the expansion of specialized gastroenterology services, and enhanced availability of innovative treatments. Key trends anticipated for this period encompass the increased application of prescription medications for long-term constipation, the wider acceptance of probiotics and digestive health products, a move towards drugs with specific mechanisms of action, an intensified focus on managing constipation linked to opioid use, and the broadening reach of online pharmacy channels.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Constipation Treatment Market?

The rising occurrence of gastrointestinal conditions is anticipated to fuel the expansion of the constipation treatment market in the coming years. Gastrointestinal disorders, also known as digestive disorders, refer to diverse health issues impacting the digestive tract, with constipation often presenting as a symptom. The increasing spread of these disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), actively drives the constipation treatment market’s growth, as these conditions are frequently linked with constipation, thereby generating a greater demand for specialized and effective treatments amidst increasing public awareness. For instance, in January 2024, the American Cancer Society, a US-based non-profit organization, estimated approximately 26,890 new cases of stomach cancer in the U.S. for 2024, with 16,160 cases in men and 10,730 in women. This type of cancer is also projected to cause about 10,880 deaths, involving 6,490 men and 4,390 women. Consequently, the growing incidence of gastrointestinal disorders is a significant factor in boosting the constipation treatment market.

What Major Segment Divisions Exist Within The Constipation Treatment Market?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

What Trends Are Projected To Affect The Constipation Treatment Market?

Leading companies in the constipation treatment market are concentrating on developing novel solutions, such as drug-free mechanical stimulation capsules (vibrating capsules). This focus aims to address the increasing demand for effective therapies with minimal side effects, a need driven by an aging population, greater opioid usage, and patient preference for non-pharmacologic alternatives. A vibrating capsule is a swallowable, single-use oral device containing a small vibration motor and a battery encased in a medical-grade, excretable shell. It is engineered to mechanically stimulate the colon at programmed times to induce peristalsis, providing predictable bowel movements without the systemic effects of laxatives or prescription prokinetics. For example, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system cleared by the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system includes a reusable activation pod and a single-use capsule, which houses a coin-sized vibration motor, an electronic control card, and batteries, all enclosed in a two-piece shell. The pod programs the capsule, which then delivers a series of short vibration cycles, approximately 190 cycles per hour with timed bursts and rests, specifically designed to stimulate colonic contractions.

Which Companies Are Leading Innovation In The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Read the full constipation treatment market report here:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

What Are The Leading Geographic Regions In The Constipation Treatment Market?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Constipation Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12134&type=smp

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Connected Health And Wellness Solutions Global Market Report

https://www.thebusinessresearchcompany.com/report/connected-health-and-wellness-solutions-global-market-report

Healthcare Services Market

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Healthcare Services Market

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795